Taking people in Belgium1. fázis
A study to evaluate the Safety, Pharmacokinetics, and Activity of Subcutaneous Cevostamab (BFCR4350A) in Patients with Relapsed or Refractory Multiple Myeloma (CAMMA 3)
Key facts
- Where
- Gent és Jette, BelgiumSee the 2 sites
- Phase
- 1. fázis
Where in Belgium
- Universitair Ziekenhuis GentGent, BelgiumTaking people
- UZ BrusselJette, BelgiumTaking people
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Trial details
- Who runs it
- Genentech Inc.
- Trial code
- EU 2023-503404-89-00
- Record updated
- 2026. augusztus 24.